good on any construction??, page-40

After listening to the conference call again it sounds like everyone is pumped up about our oncology platform and moving forward in Ph'3's etc. It was even suggested that people need to start looking at oncology as a billion dollar market cap, not a million dollar! ;) It was also good to hear positives regarding Fonda- Pete even hinted that earnings could end up at the high end of evaluations- aka 30mil + p/a in the US alone.

What I’m still baffled about though is why they want to give back 90% of Fonda earnings to investors?? Sure they mentioned tax credits etc etc, but I still can't get my head around it. It also sounds like the initial evaluation for oncology will be significant- 100-150mil + perhaps?? But why do we even need an IPO for this, why do we even need to split? WE HAVE EARNINGS FROM FONDA, sure the true value of our assets/ oncology might not be reflected for a few years- but Fonda earnings could potentially fund a whole platform worth of trails without a partner, or without further dilution. It would be like having fully sponsored trails right through to ph3! That would be unreal- What other company with a market cap our size could actually do that?? If oncology is as successful as we all hope, then wouldn't shareholders stand for far greater reward in the LT if we stayed under one company?

IMO.